AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Running at a loss is a significant concern for many businesses as they navigate increased competition and challenges in securing funding. However, it is possible to identify companies that could emerge as industry leaders, alongside those that present more uncertain prospects.
Domo, a provider of business intelligence software, allows real-time access and visualization of business metrics. Despite its innovative offerings,
has faced declining billings, averaging a 2.4% decrease over the last year. This, coupled with hefty customer acquisition costs and a short cash runway, suggests potential financial turbulence and the risk of shareholder dilution. Given that Domo is trading at two times its forward price-to-sales, investors may want to deliberate before adding it to their portfolios.Bally's Corporation, a diversified casino-entertainment entity, has also struggled to meet market expectations. With a revenue growth of just 2.9% over the past two years, it is falling short relative to consumer discretionary sector standards. Declining returns on capital and limited cash reserves imply that
might face challenging financing conditions in the future, potentially leading to shareholder dilution. Currently trading at 1.8 times forward EV-to-EBITDA, presents several investment risks.On the other hand,
stands out as a promising candidate. As a leading provider of software development tools, it has demonstrated impressive annual recurring revenue growth of 31.7% over the last year, coupled with an outstanding gross margin of 88.6%. This indicates a strong customer base willing to commit to its offerings. Its enhanced operating profits and efficiency further bolster the company’s potential as a lucrative investment. GitLab is currently valued at 6.7 times its forward price-to-sales, inviting interest from investors looking for high-growth opportunities.Other noted companies facing profitability challenges include Zillow,
, and . Zillow has experienced a 7.8% annual sales decline over the last five years, indicating difficulties connecting its products to the market, alongside poor expense management. This has affected its stock price, trading at 43.3 times forward price-to-earnings, leading us to conclude that it may not meet the investment standards.Similarly, Masimo, known for developing noninvasive patient monitoring technologies, is witnessing sales declines of 18.4% over the past two years. Subpar constant currency growth suggests needed product improvements. Since its shares trade at a forward price-to-earnings ratio of 30.5, investors might approach with caution.
Xerox, renowned for its document management systems and office technology, reported a 4.9% annual sales decline over the past five years. This trend, combined with waning returns on capital and substantial leverage, poses potential risks, including shareholder dilution. Its valuation stands at 2.7 times forward price-to-earnings.
While some of these companies exhibit challenges, others like GitLab provide compelling opportunities. Identifying which unprofitable companies have the potential to transition to profitable growth is crucial for informed investment decisions.
Stay ahead with real-time Wall Street scoops.

Nov.30 2025

Nov.30 2025

Nov.29 2025

Nov.29 2025

Nov.29 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet